Lifitegrast
Lifitegrast is a pharmaceutical drug with 15 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 10 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
3
Mid Stage
9
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
76.9%
10 of 13 finished
23.1%
3 ended early
1
trials recruiting
15
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease
Lifitegrast Eye Drops in Healthy Subjects：Phase I Study
Examining the Clinical Characteristics, Treatment Patterns, Real-world Effectiveness, and Healthcare Resource Utilization of Patients With Dry Eye Disease
Clinical Efficacy of Two Topical Dry Eye Drops for Central Corneal Stain Clearing Over 90 Days
A Study Evaluating the Efficacy of SAR 1118 (0.1%, 1.0%, 5.0%) Ophthalmic Solution in Subjects With Dry Eye Conducted in a Controlled Adverse Environment (CAE)
Clinical Trials (15)
A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease
Lifitegrast Eye Drops in Healthy Subjects：Phase I Study
Examining the Clinical Characteristics, Treatment Patterns, Real-world Effectiveness, and Healthcare Resource Utilization of Patients With Dry Eye Disease
Clinical Efficacy of Two Topical Dry Eye Drops for Central Corneal Stain Clearing Over 90 Days
A Study Evaluating the Efficacy of SAR 1118 (0.1%, 1.0%, 5.0%) Ophthalmic Solution in Subjects With Dry Eye Conducted in a Controlled Adverse Environment (CAE)
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Efficacy Study to Evaluate the Effectiveness of 3 Concentrations of SAR 1118 in Allergic Conjunctivitis
Safety and Efficacy Study of SAR 1118 to Treat Dry Eye Conducted in a Controlled Adverse Environment (CAE) (OPUS-1)
A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)
Safety Study of Lifitegrast to Treat Dry Eye
The Effect Of Lifitegrast On Refractive Accuracy And Symptoms In Dry Eye Patients Undergoing Cataract Surgery
Effects of Xiidra on Closed Eye Tear Film Leukocytes in Dry Eye Disease
Use of 5.0% Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease in Contact Lens Wearers
Lifitegrast 5% Ophthalmic Solution and Contact Lens Dryness
Effect of Lifitegrast on Dry Eye Disease Signs and Symptoms
All 15 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 15